• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重度克罗恩病的预测因素。

Predictors of severe Crohn's disease.

作者信息

Loly Catherine, Belaiche Jacques, Louis Edouard

机构信息

Department of Gastroenterology, CHU of Liège, GIGA Research University of Liège, Belgium.

出版信息

Scand J Gastroenterol. 2008 Aug;43(8):948-54. doi: 10.1080/00365520801957149.

DOI:10.1080/00365520801957149
PMID:19086165
Abstract

OBJECTIVE

A model based on clinical characteristics at diagnosis and predicting the early development of disabling Crohn's disease (CD) has recently been proposed in order to target patients for early intervention. The objectives of this study were to confirm the predictive factors established in a previous study and to establish the predictive factors for the development of severe disease characterized by the development of clinically significant non-reversible damage.

MATERIAL AND METHODS

Our retrospective study comprised a total of 361 patients with CD from our clinical database with a follow-up of longer than 5 years. Clinical, demographic and biological factors associated with the development of disabling disease (according to predefined criteria) within 5 years after the diagnosis of CD and with the time to development of severe disease (according to predefined criteria) were successively studied by univariate and multivariate analyses.

RESULTS

The rate of disabling CD within 5 years after diagnosis was 57.9%. Perianal lesions, the need for steroids to treat the first flare and ileo-colonic location, but not age below 40 years were confirmed as predictive markers. The rate of severe disease was 37.4%. Stricturing behaviour (HR: 2.11 (95% CI: 1.39-3.20)) and loss of weight (> 5 kg) (HR: 1.67 (95% CI: 1.14-2.45)) at diagnosis were independently associated with the time to development of severe disease. The predictive performances of the models generated were low.

CONCLUSIONS

Disabling and severe CD developed in roughly one-third and two-thirds of our patients, respectively. Some clinical predictive markers could be found or even confirmed but their performances were low.

摘要

目的

最近提出了一种基于诊断时临床特征并预测致残性克罗恩病(CD)早期发展的模型,以便针对患者进行早期干预。本研究的目的是确认先前研究中确定的预测因素,并确定以临床上显著的不可逆损伤发展为特征的严重疾病发展的预测因素。

材料与方法

我们的回顾性研究共纳入了来自临床数据库的361例CD患者,随访时间超过5年。通过单因素和多因素分析,依次研究了与CD诊断后5年内致残性疾病(根据预定义标准)发展以及严重疾病发展时间(根据预定义标准)相关的临床、人口统计学和生物学因素。

结果

诊断后5年内致残性CD的发生率为57.9%。肛周病变、首次发作时需要使用类固醇治疗以及回结肠部位,但40岁以下年龄不是预测指标,这些均被确认为预测标志物。严重疾病的发生率为37.4%。诊断时的狭窄行为(HR:2.11(95%CI:1.39 - 3.20))和体重减轻(>5kg)(HR:1.67(95%CI:1.14 - 2.45))与严重疾病发展时间独立相关。所生成模型的预测性能较低。

结论

在我们的患者中,分别约有三分之一和三分之二发生了致残性和严重CD。可以找到甚至确认一些临床预测标志物,但其性能较低。

相似文献

1
Predictors of severe Crohn's disease.重度克罗恩病的预测因素。
Scand J Gastroenterol. 2008 Aug;43(8):948-54. doi: 10.1080/00365520801957149.
2
The Risk of Developing Disabling Crohn's Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making.发展为致残性克罗恩病的风险:用于改善治疗决策的临床预测规则的验证
Dig Dis. 2023;41(6):879-889. doi: 10.1159/000531789. Epub 2023 Aug 23.
3
A risk score system to timely manage treatment in Crohn's disease: a cohort study.一种用于克罗恩病治疗及时管理的风险评分系统:一项队列研究。
BMC Gastroenterol. 2018 Nov 6;18(1):164. doi: 10.1186/s12876-018-0889-5.
4
Predictors of Crohn's disease.克罗恩病的预测因素。
Gastroenterology. 2006 Mar;130(3):650-6. doi: 10.1053/j.gastro.2005.12.019.
5
Clinical predictors at diagnosis of disabling pediatric Crohn's disease.诊断为致残性小儿克罗恩病的临床预测因素。
Inflamm Bowel Dis. 2012 Nov;18(11):2072-8. doi: 10.1002/ibd.22898. Epub 2012 Jan 31.
6
Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort.预测复杂克罗恩病和手术:基于人群队列的表型、遗传学、血清学和心理特征。
Aliment Pharmacol Ther. 2013 Aug;38(3):274-83. doi: 10.1111/apt.12368. Epub 2013 Jun 3.
7
Slight increases in the disease activity index and platelet count imply the presence of active intestinal lesions in C-reactive protein-negative Crohn's disease patients.疾病活动指数和血小板计数略有升高意味着C反应蛋白阴性的克罗恩病患者存在活动性肠道病变。
Intern Med. 2014;53(17):1905-11. doi: 10.2169/internalmedicine.53.2627. Epub 2014 Sep 1.
8
Clinical prognostic factors for disabling Crohn's disease: a systematic review and meta-analysis.影响致残性克罗恩病的临床预后因素:系统评价和荟萃分析。
World J Gastroenterol. 2013 Jun 28;19(24):3866-71. doi: 10.3748/wjg.v19.i24.3866.
9
Impact of disease location on fecal calprotectin levels in Crohn's disease.疾病部位对克罗恩病粪便钙卫蛋白水平的影响。
Scand J Gastroenterol. 2015 Jul;50(7):841-7. doi: 10.3109/00365521.2015.1008035. Epub 2015 Jan 30.
10
Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn's Disease: Results from the CONNECT Study.基于克罗恩病患者诊断时C反应蛋白水平的疾病表型、活动度及临床病程预测:CONNECT研究结果
Gut Liver. 2016 Jul 15;10(4):595-603. doi: 10.5009/gnl15411.

引用本文的文献

1
Magnetic resonance enterography to predict subsequent disabling Crohn's disease in newly diagnosed patients (METRIC-EF)-multivariable prediction model, multicentre diagnostic inception cohort.磁共振小肠造影预测新诊断患者中后续致残性克罗恩病(METRIC-EF)-多变量预测模型,多中心诊断性起始队列研究
Eur Radiol. 2025 May 14. doi: 10.1007/s00330-025-11636-8.
2
Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?炎症性肠病中生物标志物的错误解读与误用:我们如何避免?
Expert Rev Gastroenterol Hepatol. 2025 Apr;19(4):359-363. doi: 10.1080/17474124.2025.2482980. Epub 2025 Mar 25.
3
Ten-year outcomes of a prospective population-based incidence cohort of inflammatory bowel disease patients from Canterbury, New Zealand.
来自新西兰坎特伯雷的炎症性肠病患者前瞻性人群发病率队列的十年随访结果。
JGH Open. 2024 Oct 14;8(10):e70038. doi: 10.1002/jgh3.70038. eCollection 2024 Oct.
4
Safety and Effectiveness of Ustekinumab for Crohn's Disease With Perianal Manifestations: Ad hoc Analysis Data From 1-Year Post-Marketing Surveillance Study in Japan.优特克单抗治疗克罗恩病肛周表现的安全性和有效性:来自日本上市后1年监测研究的特设分析数据。
Crohns Colitis 360. 2024 May 16;6(2):otae035. doi: 10.1093/crocol/otae035. eCollection 2024 Apr.
5
Precision medicine in inflammatory bowel disease.炎症性肠病中的精准医学。
Precis Clin Med. 2023 Dec 18;6(4):pbad033. doi: 10.1093/pcmedi/pbad033. eCollection 2023 Dec.
6
Bowel Stiffness Assessed by Shear-Wave Ultrasound Elastography Predicts Disease Behavior Progression in Patients With Crohn's Disease.通过剪切波超声弹性成像评估的肠壁硬度可预测克罗恩病患者的疾病行为进展。
Clin Transl Gastroenterol. 2024 Apr 1;15(4):e00684. doi: 10.14309/ctg.0000000000000684.
7
A Logistic Regression Model for Predicting the Risk of Subsequent Surgery among Patients with Newly Diagnosed Crohn's Disease Using a Brute Force Method.一种使用暴力法预测新诊断克罗恩病患者后续手术风险的逻辑回归模型。
Diagnostics (Basel). 2023 Dec 3;13(23):3587. doi: 10.3390/diagnostics13233587.
8
Therapeutic Targets for Emerging Biologic Therapies in IBD.炎症性肠病新兴生物疗法的治疗靶点
Gastroenterol Hepatol (N Y). 2009 Jul;5(7 Suppl 16):4-16.
9
Evaluation of Albumin, Transferrin and Transthyretin in Inflammatory Bowel Disease Patients as Disease Activity and Nutritional Status Biomarkers.评估炎症性肠病患者的白蛋白、转铁蛋白和甲状腺素结合前白蛋白作为疾病活动和营养状况的生物标志物。
Nutrients. 2023 Aug 7;15(15):3479. doi: 10.3390/nu15153479.
10
Precision medicine and drug optimization in adult inflammatory bowel disease patients.成人炎症性肠病患者的精准医学与药物优化
Therap Adv Gastroenterol. 2023 May 10;16:17562848231173331. doi: 10.1177/17562848231173331. eCollection 2023.